Supreme Court seems likely to preserve access to the abortion medication mifepristone

By MARK SHERMAN
Associated Press

WASHINGTON (AP) — The Supreme Court seems likely to preserve access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year, in the court’s first abortion case since conservative justices overturned Roe v. Wade two years ago. In nearly 90 minutes of arguments Tuesday, a consensus appeared to emerge that the abortion opponents who challenged the FDA’s approval of the medication, mifepristone, and subsequent actions to ease access to it lack the legal right, or standing, to sue. Such a decision would leave the current rules in place, including sending the drug through the mail. The election-year decision is expected by early summer. Mifepristone, one of two drugs used in medication abortions, is made by New York-based Danco Laboratories.